{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:59:26Z","timestamp":1791349166491,"version":"4.3.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140741","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T18:15:23Z","timestamp":1445364923000},"page":"e0140741","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase"],"prefix":"10.1371","volume":"10","author":[{"given":"Safiatou T.","family":"Coulibaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rossolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska K.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Bray\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Negroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2012.05.023","article-title":"Suicide gene therapy in cancer: where do we stand now?","volume":"324","author":"S Duarte","year":"2012","journal-title":"Cancer Lett"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.mt.6300190","article-title":"The suicide gene therapy challenge: how to improve a successful gene therapy approach","volume":"15","author":"C Bonini","year":"2007","journal-title":"Mol Ther"},{"issue":"5319","key":"ref3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukaemia","volume":"276","author":"C Bonini","year":"1997","journal-title":"Science"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ymthe.2004.08.002","article-title":"AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study","volume":"10","author":"A Immonen","year":"2004","journal-title":"Mol Ther"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0022-5347(05)67534-9","article-title":"Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer","volume":"163","author":"M Shalev","year":"2000","journal-title":"J Urol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"C Berger","year":"2006","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.bi.57.070188.002025","article-title":"Interactions between deoxyribonucleotide and DNA synthesis","volume":"57","author":"P Reichard","year":"1988","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1200\/JCO.1994.12.8.1535","article-title":"Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study","volume":"12","author":"RP Abratt","year":"1994","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1200\/JCO.1994.12.9.1821","article-title":"Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study","volume":"12","author":"H Anderson","year":"1994","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1995.13.11.2731","article-title":"Advanced breast cancer: a phase II trial with gemcitabine","volume":"13","author":"J Carmichael","year":"1995","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00873232","article-title":"Phase II trial of gemcitabine (2,2&apos;-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas","volume":"12","author":"ES Casper","year":"1994","journal-title":"Invest New Drugs"},{"issue":"20","key":"ref12","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/86.20.1530","article-title":"Phase II study of gemcitabine (2&apos;,2&apos;-difluorodeoxycytidine) in previously treated ovarian cancer patients","volume":"86","author":"B Lund","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"3 Suppl","key":"ref13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<633::AID-CNCR44>3.0.CO;2-X","article-title":"Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review","volume":"78","author":"M Moore","year":"1996","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1748-717X-8-223","article-title":"New insights into the synergism of nucleoside analogs with radiotherapy","volume":"8","author":"MW Lee","year":"2013","journal-title":"Radiat Oncol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V81.3.597.597","article-title":"Relationship of deoxycytidine kinase and cytoplasmic 5&apos;-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine","volume":"81","author":"H Kawasaki","year":"1993","journal-title":"Blood"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1477-3","article-title":"Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs","volume":"131","author":"EJ Geutjes","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0006-291X(02)00413-8","article-title":"Cytotoxic activity of 2&apos;,2&apos;-difluorodeoxycytidine, 5-aza-2&apos;-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene","volume":"293","author":"CM Beausejour","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1368-7646(02)00002-X","article-title":"Determinants of resistance to 2&apos;,2&apos;-difluorodeoxycytidine (gemcitabine)","volume":"5","author":"AM Bergman","year":"2002","journal-title":"Drug Resist Updat"},{"issue":"10","key":"ref19","first-page":"3263","article-title":"Tumor uptake and elimination of 2&apos;,2&apos;-difluoro-2&apos;-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response","volume":"7","author":"AW Blackstock","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref20","first-page":"371","article-title":"Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity","volume":"1","author":"JR Kroep","year":"2002","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"ref21","first-page":"2343","article-title":"Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity","volume":"56","author":"DM Hapke","year":"1996","journal-title":"Cancer Res"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0596-567","article-title":"Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo","volume":"2","author":"Y Manome","year":"1996","journal-title":"Nat Med"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0959-8049(00)00246-X","article-title":"Cross-resistance in the 2&apos;,2&apos;-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs","volume":"36","author":"AM Bergman","year":"2000","journal-title":"Eur J Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-4-8","article-title":"Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene","volume":"4","author":"CM Galmarini","year":"2004","journal-title":"BMC Pharmacol"},{"issue":"11","key":"ref25","first-page":"5029","article-title":"Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine","volume":"44","author":"K Bhalla","year":"1984","journal-title":"Cancer Res"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood.V61.4.660.660","article-title":"Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells","volume":"61","author":"A Cohen","year":"1983","journal-title":"Blood"},{"issue":"5","key":"ref27","first-page":"780","article-title":"Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukaemia and resistance to cytosine arabinoside","volume":"8","author":"M Flasshove","year":"1994","journal-title":"Leukaemia"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsb942","article-title":"Structure of human dCK suggests strategies to improve anticancer and antiviral therapy","volume":"10","author":"E Sabini","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"14","key":"ref29","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/bi2001032","article-title":"Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release","volume":"50","author":"S Hazra","year":"2011","journal-title":"Biochemistry"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.febslet.2008.01.048","article-title":"Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues","volume":"582","author":"T McSorley","year":"2008","journal-title":"FEBS Lett"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0005-2787(68)90124-X","article-title":"Studies on a new mechanism of resistance of L5178Y murine leukaemia cells to cytosine arabinoside","volume":"161","author":"RL Momparler","year":"1968","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00694338","article-title":"Chemotherapy of L1210 and L1210\/ARA-C leukaemia with 5-aza-2&apos;-deoxycytidine and 3-deazauridine","volume":"25","author":"RL Momparler","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-006-0195-8","article-title":"Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells","volume":"58","author":"LP Jordheim","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"e1002904","DOI":"10.1371\/journal.pgen.1002904","article-title":"Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation","volume":"8","author":"P Rossolillo","year":"2012","journal-title":"PLoS Genet"},{"issue":"5259","key":"ref35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"L Naldini","year":"1996","journal-title":"Science"},{"issue":"20","key":"ref36","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1073\/pnas.91.20.9564","article-title":"A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes","volume":"91","author":"JK Yee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"ref37","doi-asserted-by":"crossref","first-page":"35163","DOI":"10.1074\/jbc.M705617200","article-title":"CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach","volume":"282","author":"AM Baker","year":"2007","journal-title":"J Biol Chem"},{"issue":"5320","key":"ref38","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1126\/science.276.5320.1874","article-title":"Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry","volume":"276","author":"O Pleskoff","year":"1997","journal-title":"Science"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"e1000418","DOI":"10.1371\/journal.ppat.1000418","article-title":"Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus","volume":"5","author":"E Simon-Loriere","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-4690-10-114","article-title":"Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality","volume":"10","author":"M Hamoudi","year":"2013","journal-title":"Retrovirology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0076-6879(78)51066-5","article-title":"Jr. Guanylate kinases from human erythrocytes, hog brain, and rat liver","volume":"51","author":"KC Agarwal","year":"1978","journal-title":"Methods Enzymol"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-011-0777-8","article-title":"Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect","volume":"89","author":"E Preuss","year":"2011","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1074\/jbc.M512129200","article-title":"Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity","volume":"281","author":"C Smal","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2003.07.001","article-title":"Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases","volume":"100","author":"AR Van Rompay","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"a006916","DOI":"10.1101\/cshperspect.a006916","article-title":"Transcriptional and posttranscriptional regulation of HIV-1 gene expression","volume":"2","author":"J Karn","year":"2012","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:58:40Z","timestamp":1599699520000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140741"}},"subtitle":[],"editor":[{"given":"Jean-Luc EPH","family":"Darlix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140741","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}